Real-time Estimate
Cboe BZX
02:00:37 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
98.54
USD
|
+0.14%
|
|
+2.63%
|
+9.36%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
33,186
|
26,966
|
37,333
|
30,974
|
49,906
|
58,835
|
-
|
-
|
Enterprise Value (EV)
1 |
48,189
|
39,162
|
51,195
|
44,890
|
63,648
|
72,899
|
74,715
|
76,151
|
P/E ratio
|
26.8
x
|
27.7
x
|
110
x
|
219
x
|
137
x
|
77.8
x
|
58.4
x
|
51.1
x
|
Yield
|
4.26%
|
4.18%
|
2.84%
|
3.72%
|
2.71%
|
2.51%
|
2.66%
|
2.84%
|
Capitalization / Revenue
|
6.48
x
|
5.85
x
|
7.87
x
|
5.29
x
|
7.52
x
|
7.5
x
|
6.88
x
|
6.09
x
|
EV / Revenue
|
9.41
x
|
8.5
x
|
10.8
x
|
7.66
x
|
9.59
x
|
9.3
x
|
8.74
x
|
7.88
x
|
EV / EBITDA
|
20.9
x
|
20.8
x
|
27.8
x
|
20.9
x
|
25.3
x
|
24.8
x
|
22.4
x
|
21.2
x
|
EV / FCF
|
54,533,993
x
|
42,640,311
x
|
89,070,113
x
|
-
|
-
|
-
|
50,929,687
x
|
39,297,860
x
|
FCF Yield
|
0%
|
0%
|
0%
|
-
|
-
|
-
|
0%
|
0%
|
Price to Book
|
2.16
x
|
1.69
x
|
2.18
x
|
1.58
x
|
2.02
x
|
2.21
x
|
2.07
x
|
2.23
x
|
Nbr of stocks (in thousands)
|
405,800
|
417,305
|
435,275
|
472,521
|
553,469
|
597,916
|
-
|
-
|
Reference price
2 |
81.78
|
64.62
|
85.77
|
65.55
|
90.17
|
98.40
|
98.40
|
98.40
|
Announcement Date
|
2/12/20
|
2/9/21
|
2/15/22
|
2/15/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,121
|
4,606
|
4,742
|
5,861
|
6,638
|
7,842
|
8,553
|
9,665
|
EBITDA
1 |
2,305
|
1,880
|
1,841
|
2,151
|
2,511
|
2,945
|
3,338
|
3,597
|
EBIT
1 |
1,278
|
841.3
|
803.3
|
841.1
|
1,110
|
1,246
|
1,619
|
1,717
|
Operating Margin
|
24.95%
|
18.27%
|
16.94%
|
14.35%
|
16.72%
|
15.89%
|
18.92%
|
17.77%
|
Earnings before Tax (EBT)
1 |
542.9
|
-31.55
|
170.8
|
173.1
|
350
|
710.6
|
1,024
|
1,334
|
Net income
1 |
1,232
|
978.8
|
336.1
|
141.2
|
340.1
|
721.4
|
982.9
|
1,068
|
Net margin
|
24.06%
|
21.25%
|
7.09%
|
2.41%
|
5.12%
|
9.2%
|
11.49%
|
11.05%
|
EPS
2 |
3.050
|
2.330
|
0.7800
|
0.3000
|
0.6600
|
1.265
|
1.686
|
1.925
|
Free Cash Flow
|
883.7
|
918.4
|
574.8
|
-
|
-
|
-
|
1,467
|
1,938
|
FCF margin
|
17.25%
|
19.94%
|
12.12%
|
-
|
-
|
-
|
17.15%
|
20.05%
|
FCF Conversion (EBITDA)
|
38.34%
|
48.86%
|
31.22%
|
-
|
-
|
-
|
43.95%
|
53.87%
|
FCF Conversion (Net income)
|
71.7%
|
93.83%
|
170.99%
|
-
|
-
|
-
|
149.25%
|
181.37%
|
Dividend per Share
2 |
3.480
|
2.700
|
2.440
|
2.440
|
2.440
|
2.472
|
2.620
|
2.794
|
Announcement Date
|
2/12/20
|
2/9/21
|
2/15/22
|
2/15/23
|
2/13/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,309
|
1,396
|
1,473
|
1,474
|
1,519
|
1,561
|
1,665
|
1,662
|
1,750
|
1,860
|
1,939
|
2,019
|
2,077
|
2,153
|
2,256
|
EBITDA
1 |
491
|
504.3
|
581.9
|
526.9
|
538.4
|
558.6
|
662.5
|
620.6
|
669.4
|
709.5
|
731.4
|
762
|
782.4
|
800.3
|
799.8
|
EBIT
1 |
206.5
|
200.2
|
271.6
|
173.2
|
196.1
|
219.5
|
320.6
|
281.3
|
288.6
|
343.6
|
332.1
|
348.5
|
367.5
|
419.2
|
-
|
Operating Margin
|
15.77%
|
14.35%
|
18.44%
|
11.75%
|
12.91%
|
14.06%
|
19.25%
|
16.93%
|
16.5%
|
18.48%
|
17.13%
|
17.26%
|
17.69%
|
19.47%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
38
|
152.3
|
72.24
|
87.46
|
140.9
|
179
|
191
|
209.5
|
221.4
|
248.1
|
Net income
1 |
58.67
|
61.92
|
89.78
|
-6.767
|
-3.728
|
25.67
|
103
|
127.5
|
83.91
|
127.1
|
178.9
|
201.3
|
203.4
|
208.4
|
217.4
|
Net margin
|
4.48%
|
4.44%
|
6.1%
|
-0.46%
|
-0.25%
|
1.64%
|
6.19%
|
7.67%
|
4.8%
|
6.84%
|
9.23%
|
9.97%
|
9.79%
|
9.68%
|
9.63%
|
EPS
2 |
0.1300
|
0.1400
|
0.2000
|
-0.0100
|
-0.0100
|
0.0500
|
0.2000
|
0.2400
|
0.1500
|
0.2200
|
0.3074
|
0.3435
|
0.3672
|
0.3725
|
0.3700
|
Dividend per Share
2 |
0.6100
|
0.6100
|
0.6100
|
0.6100
|
0.6100
|
-
|
0.6100
|
0.6100
|
0.6100
|
-
|
0.6117
|
0.6133
|
0.6183
|
0.6533
|
0.6667
|
Announcement Date
|
2/15/22
|
5/10/22
|
8/9/22
|
11/7/22
|
2/15/23
|
5/2/23
|
7/31/23
|
10/30/23
|
2/13/24
|
4/29/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,003
|
12,196
|
13,862
|
13,916
|
13,742
|
14,064
|
15,880
|
17,316
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.51
x
|
6.488
x
|
7.53
x
|
6.468
x
|
5.472
x
|
4.776
x
|
4.757
x
|
4.814
x
|
Free Cash Flow
|
884
|
918
|
575
|
-
|
-
|
-
|
1,467
|
1,938
|
ROE (net income / shareholders' equity)
|
8.17%
|
6.21%
|
2%
|
0.74%
|
1.49%
|
2.67%
|
3.62%
|
4.28%
|
ROA (Net income/ Total Assets)
|
3.87%
|
2.97%
|
1%
|
0.39%
|
0.83%
|
1.6%
|
2.4%
|
3%
|
Assets
1 |
31,861
|
32,932
|
33,698
|
36,405
|
40,951
|
45,085
|
40,997
|
35,613
|
Book Value Per Share
2 |
37.90
|
38.30
|
39.40
|
41.40
|
44.70
|
44.60
|
47.60
|
44.10
|
Cash Flow per Share
2 |
3.800
|
3.270
|
2.990
|
2.860
|
3.090
|
3.830
|
4.550
|
5.030
|
Capex
1 |
652
|
446
|
701
|
1,108
|
1,533
|
1,323
|
1,078
|
932
|
Capex / Sales
|
12.74%
|
9.69%
|
14.77%
|
18.9%
|
23.09%
|
16.87%
|
12.6%
|
9.64%
|
Announcement Date
|
2/12/20
|
2/9/21
|
2/15/22
|
2/15/23
|
2/13/24
|
-
|
-
|
-
|
Last Close Price
98.4
USD Average target price
104.6
USD Spread / Average Target +6.26% Consensus |
1st Jan change
|
Capi.
|
---|
| +9.36% | 58.83B | | -4.77% | 19.2B | | -2.17% | 13.48B | | +0.46% | 7.62B | | -13.64% | 5.84B | | +10.28% | 3.53B | | +2.03% | 3.44B | | -0.39% | 3.24B | | +17.48% | 2.85B | | -6.21% | 2.7B |
Healthcare REITs
|